Mar 27, 2015
"We used to think that our fate was in our stars, but now we know that, in large measure, our fate is in our genes, "quotes James Watson. This fate that Watson is talking about is contained in our genes, and deals with a new technique, GENE THERAPY. Gene therapy is an innovative way to fix genetic problem from th...
Read More...
Mar 13, 2015
Antibody-Drug Conjugates-A Big Boom! Therapeutics developed to create innovative medicines based on the use of new and improved antibodies is the next generation cure for the treatment of various diseases. In past decade, the antibody drug conjugates have emerged out as the active areas of many biopharmaceutical ...
Read More...
Mar 05, 2015
Looking for Passionate Candidates Mail your updated Resume to careers@delveinsight.com www.delveinsight.com Twitter, Facebook, LinkedIn JOB DESCRIPTION Profile Offered: Associate Analyst Education: M. Pharma/M.tech Biotech Roles and Responsibilities: Conduct market research through primary and secondary sou...
Read More...
Mar 03, 2015
Antibody–drug conjugates (ADCs), a new weapon of 21st Century for fighting Cancer Traditional cancer chemotherapy was having harsh side effects and also leads to systemic toxicity. The approach was also referred to as the carpet-bombing strategy for fighting cancer. Traditional chemotherapy does not discriminate b...
Read More...
Feb 27, 2015
Thanks to our great Clients, Partners, Colleagues, Family and Friends, we're celebrating the completion of our first year in business. Thanks for helping to make DelveInsight a success!!
Read More...
Dec 23, 2014
Gene Therapy: The “Promise” to cure Gastrointestinal disorders! About Gastrointestinal disorders Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestions, the liver, gallblad...
Read More...
Dec 22, 2014
Gene Therapy to “fix” Genetic disorders! "We used to think that our fate was in our stars, but now we know that, in large measure, our fate is in our genes, "quotes James Watson. This fate and our future is locked in our genes, and Gene therapy is unlocking these doors. Many physicians are predicting that in twent...
Read More...
Nov 05, 2014
Get Market Intelligence of Hemophilia Market with DelveInsight The Haemophilia Market is driven by clotting factor concentrates. Besides hemophilia A and B, and those with von Willebrand disease (VWD), is also sometimes treated with clotting factor. Currently about 20,000 people have hemophilia in the US; about ...
Read More...
Aug 27, 2014
DelveInsight is helping worldwide Pharmaceutical companies with its Market Intelligence Reports. VISIT OUR WEBSITE Infectious Diseases and Vaccines The infectious disease (ID) vaccine pipeline is rich and robust. However, indications such as HIV, Tuberculosis and HCV have high demand for the development of a fi...
Read More...
Aug 20, 2014
Get informed about the Current Drugs in Pipeline with DelveInsight “'Ebola Viral Infections-Pipeline Insights, 2014′, Report About Virus Ebola virus disease (formerly known as Ebola haemorrhagic fever) is a severe, often fatal illness, with a case fatality rate of up to 90%. Ebola first appeared in 197...
Read More...
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Newsletter/Whitepaper